Ahalya Malachira

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial

Nathan J. Brendish, Ahalya Malachira, Lawrence Armstrong et al. · The Lancet Respiratory Medicine · 2017 · 320 citations · Full text

Pharmacy, Infectious Diseases, Antimicrobial Stewardship +16

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Guy Thwaites, Matthew Scarborough, Alexander J. Szubert et al. · The Lancet · 2017 · 187 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

Tristan Clark, Kate Beard, Nathan J. Brendish et al. · The Lancet Respiratory Medicine · 2020 · 50 citations · Full text

Veterinary Medicine, Infectious Diseases, Outcomes Research +7

Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)

Nathan J. Brendish, Ahalya Malachira, Tristan Clark · BMC Infectious Diseases · 2017 · 34 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial

Nathan J. Brendish, Kate Beard, Ahalya Malachira et al. · The Lancet Infectious Diseases · 2023 · 28 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +17